Literature DB >> 24514917

Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.

Clara Guaschino1, Federica Esposito, Giuseppe Liberatore, Bruno Colombo, Pietro Annovazzi, Emanuele D'Amico, Paola Cavalla, Elisabetta Capello, Ruggero Capra, Daniela Galimberti, Gioacchino Tedeschi, Luigi Grimaldi, Maurizio Leone, Sandra D'Alfonso, Vittorio Martinelli, Giancarlo Comi, Filippo Martinelli-Boneschi.   

Abstract

Multiple sclerosis (MS) is a complex disease triggered by environmental and genetic agents, and clinically characterized by bout onset (BOMS) or progressive onset (PrMS). We collected clinical and familial aggregation data in a cohort of 518 Italian PrMS patients, and compared with 400 BOMS cases. An increased prevalence of MS in first-degree relatives of Italian PrMS was found. Familial aggregation is not influenced by probands' clinical course, and there is no disease course concordance within MS families. These data are useful in counseling MS patients affected with different clinical courses of the disease.

Entities:  

Mesh:

Year:  2014        PMID: 24514917     DOI: 10.1007/s10072-014-1650-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Natural history of primary progressive multiple sclerosis.

Authors:  George C Ebers
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

2.  Natural history of multiple sclerosis: a unifying concept.

Authors:  Christian Confavreux; Sandra Vukusic
Journal:  Brain       Date:  2006-01-16       Impact factor: 13.501

3.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

4.  Familial effects on the clinical course of multiple sclerosis.

Authors:  A E Hensiek; S R Seaman; L F Barcellos; A Oturai; M Eraksoi; E Cocco; L Vecsei; G Stewart; B Dubois; J Bellman-Strobl; M Leone; O Andersen; K Bencsik; D Booth; E G Celius; H F Harbo; S L Hauser; R Heard; J Hillert; K-M Myhr; M G Marrosu; J R Oksenberg; C Rajda; S J Sawcer; P S Sørensen; F Zipp; D A S Compston
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

5.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

Review 6.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

Review 7.  Primary-progressive multiple sclerosis.

Authors:  David H Miller; Siobhan M Leary
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

  7 in total
  3 in total

1.  Prediction of Multiple sclerosis disease using machine learning classifiers: a comparative study.

Authors:  Sonia Darvishi; Omid Hamidi; Jalal Poorolajal
Journal:  J Prev Med Hyg       Date:  2021-04-29

2.  Multiple Sclerosis Associated Risk Factors: A Case-Control Study.

Authors:  Jalal Poorolajal; Mehrdokht Mazdeh; Mohammad Saatchi; Elaheh Talebi Ghane; Azam Biderafsh; Bahar Lotfi; Mohammad Feryadres; Khabat Pajohi
Journal:  Iran J Public Health       Date:  2015-11       Impact factor: 1.429

3.  Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.

Authors:  Sharareh Eskandarieh; Narges Sistany Allahabadi; Malihe Sadeghi; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2018-02-07       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.